Ildong Holdings Co., Ltd. (KRX:000230)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,500
-150 (-1.10%)
Last updated: Dec 18, 2025, 2:52 PM KST
93.41%
Market Cap154.14B
Revenue (ttm)620.44B
Net Income (ttm)67.54B
Shares Out11.29M
EPS (ttm)5,328.78
PE Ratio2.66
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume190,604
Average Volume580,325
Open13,550
Previous Close13,650
Day's Range13,270 - 13,820
52-Week Range5,750 - 17,170
Beta0.55
RSI52.32
Earnings DateFeb 6, 2026

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Sector Healthcare
Founded 1941
Employees 72
Stock Exchange Korea Stock Exchange
Ticker Symbol 000230
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.